Back
Lineage Cell Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
48
LCTX
Lineage Cell Therapeutics
Last Price:
$1.03
Seasonality Move:
4.41%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LCTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Lineage Cell Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1 | Buy |
20-day SMA: | 0.95 | Buy |
50-day SMA: | 0.71 | Buy |
200-day SMA: | 0.66 | Buy |
8-day EMA: | 0.65 | Buy |
20-day EMA: | 0.34 | Buy |
50-day EMA: | 0.15 | Buy |
200-day EMA: | 0.04 | Buy |
Lineage Cell Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 63.46 | Buy |
Chaikin Money Flow: | 1042432 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.77 - 1.03) | Buy |
Bollinger Bands (100): | (0.42 - 0.8) | Buy |
Lineage Cell Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Lineage Cell Therapeutics Stock
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 1.03 while LCTX 8-day simple moving average is 1.00, which is a Buy signal.
-
The stock price of LCTX is 1.03 while Lineage Cell Therapeutics 20-day SMA is 0.95, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day simple moving average is 0.71 while LCTX share price is 1.03, making it a Buy technically.
-
LCTX stock price is 1.03 and Lineage Cell Therapeutics 200-day simple moving average is 0.66, creating a Buy signal.
LCTX Technical Analysis vs Fundamental Analysis
Sell
48
Lineage Cell Therapeutics (LCTX)
is a Sell
Is Lineage Cell Therapeutics a Buy or a Sell?
-
Lineage Cell Therapeutics stock is rated a SellThe current Lineage Cell Therapeutics [LCTX] share price is $1.03. The Score for LCTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Lineage Cell Therapeutics Stock Info
Market Cap:
235.2M
Price in USD:
1.03
Share Volume:
1M
Lineage Cell Therapeutics 52-Week Range
52-Week High:
1.15
52-Week Low:
0.37
Sell
48
Lineage Cell Therapeutics (LCTX)
is a Sell
Lineage Cell Therapeutics Share Price Forecast
-
What is the Lineage Cell Therapeutics stock price today?The Lineage Cell Therapeutics stock price is 1.03 USD today.
-
Will LCTX stock go up or go down?Lineage Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Lineage Cell Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lineage Cell Therapeutics is overvalued.
Is Lineage Cell Therapeutics Stock a Buy?
-
Lineage Cell Therapeutics share price is 1.03 while LCTX 8-day exponential moving average is 0.65, which is a Buy signal.
-
The stock price of LCTX is 1.03 while Lineage Cell Therapeutics 20-day EMA is 0.34, which makes it a Buy.
-
Lineage Cell Therapeutics 50-day exponential moving average is 0.15 while LCTX share price is 1.03, making it a Buy technically.
-
LCTX stock price is 1.03 and Lineage Cell Therapeutics 200-day simple moving average is 0.04, creating a Buy signal.
Fundamental Analysis of Lineage Cell Therapeutics
Is Lineage Cell Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.
Technical Analysis of Lineage Cell Therapeutics
Should I short Lineage Cell Therapeutics stock?
-
LCTX Moving Average Covergence Divergence (MACD) indicator is 0.23, suggesting Lineage Cell Therapeutics is a Buy
-
Lineage Cell Therapeutics Relative Strength Index (RSI) is 63.46, which suggest Lineage Cell Therapeutics is overbought
-
The Bollinger Bands (25) for Lineage Cell Therapeutics is (0.77 - 1.03), which suggest Lineage Cell Therapeutics is a Buy
-
The Bollinger Bands (100) for Lineage Cell Therapeutics is (0.42 - 0.8), which suggest Lineage Cell Therapeutics is a Buy
* Lineage Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.